Shenzhen Chipscreen Biosciences Hits Day Low Amid Price Pressure at CNY 27.89

Shenzhen Chipscreen Biosciences Co., Ltd. experienced a significant decline today, with the stock dropping by 8.9% and reaching an intraday low of CNY 27.89. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.05% on the same day. Despite the day's downturn, Shenzhen Chipscreen has shown resilience over the past month, with a 12.2% increase compared to the Shanghai Composite's decline of 8.37%. However, the company's one-year performance reflects a more challenging landscape, with a decrease of 20.14%, while the market index has gained 7.03% during the same period. Financial metrics indicate a complex situation for Shenzhen Chipscreen. The company has reported a low return on capital employed (ROCE) of 0% and a negative net worth, raising concerns about its management efficiency. Nevertheless, recent quarterly results have shown substantial growth in pre-tax profit and net profit, suggesting some positive momentum. With a market capitalization of CNY 9,986 million, Shenzhen Chipscreen operates within the pharmaceuticals and biotechnology sector, characterized by a P/E ratio of 102.00 and a dividend yield of 0.24%.